FDA Inspection
Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs PharmacyFDA Inspection 1015476 - Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy - May 22, 2017
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy, with an inspection on May 22, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- May 22, 2017
- Product Type
- Drugs
Open in Dashboard
ID · 2331290f-5f8e-4072-9e69-ab70fefd01fc
Violation Codes6
21 CFR 211.113(b)21 CFR 211.165(b)21 CFR 211.166(a)21 CFR 211.167(a)21 CFR 211.28(a)21 CFR 211.42(c)(10)(iv)
Full citation text and observation details available on the Dashboard.